1. Home
  2. QTRX vs SENS Comparison

QTRX vs SENS Comparison

Compare QTRX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.92

Market Cap

306.0M

Sector

Industrials

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$6.74

Market Cap

308.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
SENS
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Machinery/Components
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
306.0M
308.5M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
QTRX
SENS
Price
$3.92
$6.74
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$11.33
$22.70
AVG Volume (30 Days)
683.1K
505.4K
Earning Date
03-02-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,632,000.00
$16,389,000.00
Revenue This Year
$25.49
$70.20
Revenue Next Year
$9.82
$59.10
P/E Ratio
N/A
N/A
Revenue Growth
64.52
19.85
52 Week Low
$3.64
$0.41
52 Week High
$8.77
$8.75

Technical Indicators

Market Signals
Indicator
QTRX
SENS
Relative Strength Index (RSI) 24.33 50.03
Support Level N/A $6.62
Resistance Level $6.27 $6.87
Average True Range (ATR) 0.29 0.40
MACD -0.09 0.07
Stochastic Oscillator 18.55 85.98

Price Performance

Historical Comparison
QTRX
SENS

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: